Clinical Trials Logo

Healthy Subjects clinical trials

View clinical trials related to Healthy Subjects.

Filter by:

NCT ID: NCT03417453 Recruiting - Cataract Clinical Trials

Eye Drop Dispensers: Safety, Efficacy and Comfort.

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

One aspect to eye drop adherence is successful instillation of the drops; however, it is well known that many patients struggle with this task. Difficulties may include aiming their drops,extending their neck, preventing excess drop leakage, avoiding contamination of the bottle tip and generating enough force to expel a drop from the bottle. Instillation aids are devices that aim to ameliorate one or more of these barriers. Several eye drop dispensers had been developed in order to improved outcomes of eye drop instillation, including improved rates of successful administration and increased patient satisfaction compared to standard eye drop bottles. In this study we aim to compare the eye drops various installation aids

NCT ID: NCT03414723 Completed - Diabetes Mellitus Clinical Trials

A Drug-Drug Interaction Study Between Sotagliflozin and Ramipril

Start date: January 15, 2018
Phase: Phase 1
Study type: Interventional

Primary Objective: To evaluate the effects of multiple-dose ramipril on the steady state pharmacokinetic (PK) parameters of sotagliflozin and its main metabolite (sotagliflozin-3-O-glucuronide) in healthy male and female subjects. Secondary Objectives: - To assess the effects of multiple-dose sotagliflozin on the PK of ramipril and its active metabolite (ramiprilat). - To assess the safety and tolerability of multiple-dose sotagliflozin with and without multiple-dose of ramipril.

NCT ID: NCT03400241 Completed - Healthy Subjects Clinical Trials

Pharmacokinetic Study Comparing Tiotropium Easyhaler and Spiriva Handihaler

Start date: February 19, 2018
Phase: Phase 1
Study type: Interventional

Absorption of inhaled tiotropium is compared between three Tiotropium Easyhaler products and Spiriva capsules inhaled via HandiHaler. All subjects will receive all products as a single dose.

NCT ID: NCT03389321 Completed - Healthy Subjects Clinical Trials

Clinical Study to Investigate Effect of Macitentan on Riociguat Pharmacokinetics

Start date: January 9, 2018
Phase: Phase 1
Study type: Interventional

Both macitentan and riociguat are indicated in the treatment of pulmonary arterial hypertension (PAH) and may be administered concomitantly. The primary objective of this study is to evaluate the effect of macitentan administered for 11 days on the pharmacokinetics (PK) (i.e., amount and time of presence in the blood of riociguat) of a single dose of riociguat in healthy male subjects.

NCT ID: NCT03389282 Recruiting - Healthy Subjects Clinical Trials

Metabolites of Tear Fluid

Metabol-T
Start date: November 1, 2013
Phase: N/A
Study type: Observational

The pilot trial evaluates the use of modified Schirmer strips and is designed to evaluate inter-individual range of metabolites in tear film.

NCT ID: NCT03385369 Completed - Healthy Subjects Clinical Trials

A Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Overweight/Obese Subjects of Japanese or Chinese Descent

Start date: January 5, 2018
Phase: Phase 1
Study type: Interventional

This is a phase I, randomized, blinded study to evaluate the safety and pharmacokinetics of MEDI0382 following single dose administration to overweight/obese subjects of Japanese or Chinese descent

NCT ID: NCT03384290 Completed - Healthy Subjects Clinical Trials

Study of a Single Dose of PRS-060 Administered by Oral Inhalation or IV Infusion in Healthy Subjects

Start date: December 8, 2017
Phase: Phase 1
Study type: Interventional

A Dose Escalating Study of PRS-060 Administered by Oral Inhalation or IV Infusion in Healthy Subjects

NCT ID: NCT03380455 Completed - Healthy Subjects Clinical Trials

Effect of Cimetidine on the Pharmacokinetics of Lucerastat in Healthy Subjects

Start date: January 9, 2018
Phase: Phase 1
Study type: Interventional

A study in healthy male subjects to investigate whether repeated administrations of cimetidine (a medication which decreases the amount of acid in the stomach) can affect the fate in the body (amount and time of presence in the blood) of lucerastat. Safety of the concomitant administration of the two treatments will also be assessed.

NCT ID: NCT03372629 Completed - Healthy Subjects Clinical Trials

A Study to Evaluate if ID-085 is Safe, Its Fate in the Body as Well as Its Potential Effects on the Body in Healthy Subjects

Start date: January 12, 2018
Phase: Phase 1
Study type: Interventional

The objective of this study is to evaluate the tolerability, safety, and pharmacokinetic of single- and multiple-ascending doses of ID-085 in healthy subjects.

NCT ID: NCT03365960 Completed - Healthy Subjects Clinical Trials

Bioavailability and Pharmacokinetic Parameters of Watermelon (Rind, Flesh and Seeds) Polyphenols

WM
Start date: January 15, 2018
Phase: N/A
Study type: Interventional

The primary objectives of the study are outlined below: 1. To investigate the relative bioavailability and absorption/kinetic profile of polyphenols after consumption of watermelon rind, flesh and seeds, respectively in an acute pilot study. 2. To study the effects of watermelon intake on endothelial function using the FMD technique and to understand the relationship between plasma metabolites, including L-citrulline and arginine, and FMD responses.